Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

German Cartel Office grants merger control clearance to Rhoen Klinikum AG for transaction with Fresenius/HELIOS


Thursday, 20 Feb 2014 07:18am EST 

Rhoen Klinikum AG:Announces that the German Cartel Office, granted merger control clearance for the transaction with Fresenius/HELIOS without restrictions and conditions.The merger control clearance comprises 40 clinics, medical centers and related companies and thus the entire sold portfolio except for the clinics in Cuxhaven, Waltershausen-Friedrichroda und Boizenburg and two management companies for medical centers.The excepted companies were, in coordination with the Cartel Office, removed from the sold portfolio already prior to the merger control clearance.The cleared transaction will for the most part be closed until end of Feb. by payment of the purchase price and transfer of the shares. 

Company Quote

50.52
-0.88 -1.71%
11:35am EST